
Comparison of heparin dosing based on actual body weight in non-obese, obese and morbidly obese critically ill patients
Author(s) -
Anthony T. Gerlach,
Jerilynn Folino,
Benjamin N. Morris,
Claire V. Murphy,
Stanislaw P Stawicki,
Charles H. Cook
Publication year - 2013
Publication title -
international journal of critical illness and injury science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.274
H-Index - 12
eISSN - 2231-5004
pISSN - 2229-5151
DOI - 10.4103/2229-5151.119200
Subject(s) - medicine , dosing , body mass index , morbidly obese , obesity , partial thromboplastin time , heparin , critically ill , weight loss , anesthesia , platelet
Obesity is endemic in the United States and obese patients are at increased risk of thromboembolism but little data are available for dosing unfractionated heparin (UFH). We evaluated the relationship between obesity and UFH efficacy during critical illness by examining UFH infusions in non-obese, obese, and morbidly obese critically ill patients.